FindTrial
Sign In

anti-CD19 CAR T-cells

BIOLOGICAL2 trials

Sponsors

KK Women's and Children's Hospital, Vinmec Research Institute of Stem Cell and Gene Technology

Conditions

B-Cell Acute Lymphoblastic LeukemiaB-Cell Non Hodgkin LymphomaB-cell Acute Lymphoblastic LeukemiaCARLarge B-cell LymphomaLymphoblastic LeukemiaLymphoblastic Leukemia in ChildrenLymphoblastic Leukemia, Acute Adult

Phase 1

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
CompletedNCT06027957
Vinmec Research Institute of Stem Cell and Gene TechnologyB-Cell Acute Lymphoblastic Leukemia, B-Cell Non Hodgkin Lymphoma
Start: 2023-08-02End: 2025-07-31Updated: 2025-08-26

Phase 2

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
RecruitingNCT05648019
KK Women's and Children's HospitalB-cell Acute Lymphoblastic Leukemia, CAR, Large B-cell Lymphoma +3
Start: 2022-03-15End: 2026-12-31Target: 40Updated: 2023-03-09